Georgia

As a premier global life sciences hub, Georgia is uniquely defined by a collaborative ecosystem that spans biopharmaceutical manufacturing, cutting-edge medical device development and world-class academic research.

Known as the "Center of Global Health," the state serves as the international headquarters for the Centers for Disease Control and Prevention (CDC) and the Center for Global Health Innovation, fostering an environment where public health and private enterprise converge.

Georgia’s biotechnology sector is currently experiencing historic growth, highlighted by multi-billion dollar investments in biologics manufacturing and a rapidly expanding footprint of over 4,000 life science organizations.

The state is a leader in healthcare innovation, particularly in health IT and digital health, leveraging the technical prowess of institutions like Georgia Tech and Emory University.

Beyond digital solutions, Georgia’s medical technology corridor is gaining acclaim for its robust clinical trial infrastructure and specialized incubators that accelerate the commercialization of Class II and Class III medical devices.

Global leaders in personalized medicine, oncology research and immunology benefit from a deep talent pipeline fed by top-tier research universities and the Medical College of Georgia.

With highly competitive tax incentives and a pro-business climate, Georgia offers a seamless pathway from initial R&D and laboratory discovery to high-volume pharmaceutical production.

This integrated approach ensures that the state remains a top destination for biotech startups and multinational corporations looking to scale within a diverse, innovation-driven economy.